I am in the industry and work in the area. Genomic tests are being used by clinicians in greater volumes. A ten minute test...Where is the proof of this or is it all just pie in the sky. I want to hear more from the executives talking about commercialisation and product development. I hear your concerns about genomic sequencing but it is getting cheaper and more accurate. Illumina have a panel test called TSO500 which clinicians use all the time. Turnaround time is of no concern to clinicians but rather accuracy and the ability to gather big data. I am all ears and don’t get me wrong...I want things to work for the patients and for the SH...I just want facts from the company.
- Forums
- ASX - By Stock
- Grail deal....BD1 is going to fly
I am in the industry and work in the area. Genomic tests are...
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.07M |
Open | High | Low | Value | Volume |
43.5¢ | 44.0¢ | 43.0¢ | $7.597K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21334 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.5¢ | 8500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21334 | 0.440 |
1 | 16566 | 0.435 |
4 | 11435 | 0.430 |
5 | 44773 | 0.425 |
1 | 12500 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.445 | 8500 | 1 |
0.450 | 24522 | 1 |
0.460 | 6850 | 1 |
0.465 | 1195 | 1 |
0.470 | 35663 | 2 |
Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online